PSI researcher Md Zakiul Hassan, the inaugural Oxford-MoH Foundation DPhil Scholar, has been recognised as 2024 ISID Emerging Leader in International Infectious Diseases. The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.
Dr Xin Hui Chan has won the competitive 2024 Barnett Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled \u2018Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician\u2019.
Researchers at NDM\u2019s Ludwig Cancer Research, the \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne and other Oxford departments report the use of surfactant-supported assembly of freestanding microscale hydrogel droplets to construct iontronic modules and biointerfaces.
An injection given during some asthma and chronic obstructive pulmonary disease (COPD) attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30 percent.
The Kenya Medical Research Institute (KEMRI) has signed a seven-year memorandum of agreement with the Wellcome Trust and the University of Oxford. Under this collaboration, Wellcome has awarded \u00a391 million (KES 15 billion) to support research over the next seven years. KEMRI have been collaborating with the Wellcome Trust and the University of Oxford on improving health through research for over 35 years.
A new study by NDM researchers and collaborators has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
OUCRU researchers from Indonesia, Nepal, and Vietnam contributed to the newly published WHO research priorities for antimicrobial resistance. These top 40 priorities, developed by the World Health Organization (WHO) with global collaborators, aim to guide research into drug-resistant infections over the next five years, with a special focus on challenges faced by low- and middle-income countries (LMICs).
Researchers at Ludwig Cancer Research have leveraged functional genomics to suppress the function of the mutant histones responsible for driving 80% of incurable childhood brain tumours.
Nicky Whiffin, Associate Professor and Sir Henry Dale Fellow at the University of Oxford\u2019s Big Data Institute and Centre for Human Genetics, has been awarded the 2025 Balfour Lecture by the Genetics Society.
Antimicrobial resistance (AMR) is a growing global health emergency that threatens to reverse decades of medical progress. In Vietnam, the issue is particularly acute in underserved regions, where healthcare resources are often limited and diagnostic tools are scarce. NDM's Oxford University Clinical Research Unit (OUCRU) and the Phu Tho Department of Health have partnered to improve antibiotic stewardship and microbiology capabilities in underserved districts of the province.
The National Institute for Health and Care Research (NIHR) has awarded the Modernising Medical Microbiology consortium \u00a311 million to address major public health threat, antimicrobial resistance. The Oxford Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, hosted by the Nuffield Department of Medicine since 2014, is one of 13 HPRUs funded by NIHR as part of an \u00a380 million funding boost.
A study led by OUCRU Indonesia and the Faculty of Medicine Universitas Indonesia (FMUI) found that 9 out of 10 hospitals, in a sample of 575 across 34 provinces of Indonesia, had a formal Antimicrobial Stewardship Programme. But only half of those had reached a development level where they could run a robust, functional stewardship programme.
The Pandemic Sciences Institute has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
Last month the final two Oxford-GSK Institute of Molecular and Computational Medicine (IMCM) Fellows were welcomed to NDM\u2019s Centre for Human Genetics. Dr Martina Hallegger and Dr Charmaine Lang join Dr Steph Fowler to build capacity in neurodegenerative disease research at the Centre.
In an exciting collaboration between academia and industry, researchers at NDM\u2019s Centre for Medicines Discovery and Boehringer Ingelheim have discovered the reaction mechanism for human ceramide synthase (CerS), which could help to form CerS-inhibiting products in the future.
Increased genomic surveillance capacity during the pandemic allowed researchers to get a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Using antibody data and mathematical modelling, a new study from researchers at the Pandemic Sciences Institute estimates annual patterns of influenza infection and protection over the past fifty years.
Professor David Aanensen, Principal Investigator at the Pandemic Sciences Institute and Big Data Institute, has been honoured with the 2025 Translational Microbiology Prize in recognition for his work in the areas of translational microbiology and genomic epidemiology.
Researchers at NDM\u2019s Oxford University Clinical Research Unit (OUCRU) have identified gene activity signatures in the blood of patients with a life-threatening form of tuberculosis.
![\"Zakiul](\"https://www.ndm.ox.ac.uk/news/md-zakiul-hassan-recognised-as-2024-isid-emerging-leader/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n